The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits

Atherosclerosis

Volumn 188, Issue 2, 2006, Pages 356-362

  Iliodromitis, Efstathios K ^a   Zoga, Anastasia ^a   Vrettou, Agathi ^a   Andreadou, Ioanna ^a   Paraskevaidis, Ioannis A ^b   Kaklamanis, Loukas ^b   Kremastinos, Dimitrios Th ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Atherosclerosis; Hypercholesterolemia; Ischemia; Postconditioning; Preconditioning

Indexed keywords

TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROMA; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HYPERCHOLESTEROLEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; STAINING;

ANIMALS; ATHEROSCLEROSIS; EVALUATION STUDIES; EVALUATION STUDIES AS TOPIC; HYPERCHOLESTEROLEMIA; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; RABBITS;

EID: 33748200727     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.11.023     Document Type: Article

References (26)

1. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
2. Liu Y., and Downey J.M. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol 263 (1992) H1107-H1112
3. Ghosh S., Standen N.B., and Galinanes M. Failure, to precondition pathological human myocardium. J Am Coll Cardiol 37 (2001) 711-718
4. Li G., Tokuno S., Tahepold P., et al. Preconditioning protects the severely atherosclerotic mouse heart. Ann Thorac Surg 71 (2001) 1296-1303
5. Szilvassy Z., Ferdinandy P., Szilvassy J., et al. The loss of pacing-induced preconditioning in atherosclerotic rabbits: role of hypercholesterolemia. J Mol Cell Cardiol 27 (1995) 2559-2569
6. Speech-Dick M.E., Baxter G.F., and Yellon D.M. Ischemic preconditioning protects hypertrophied myocardium. Cardiovasc Res 28 (1994) 1025-1029
7. Hadour G., Ferrera R., Sebbag L., et al. Improved myocardial tolerance to ischemia in the diabetic rabbit. J Mol Cell Cardiol 30 (1998) 1869-1875
8. Przyklenk K., Li G., and Whittaker P. No loss in the in vivo efficacy of ischemic preconditioning in middle-aged and old rabbits. J Am Coll Cardiol 38 (2001) 1741-1747
9. Zhao Z.Q., Corvera J.S., Halkos M.E., et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol 285 (2003) H579-H588
10. Yang X.M., Philipp S., Downey J.M., and Cohen M.V. Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Basic Res Cardiol 100 (2005) 57-63
11. Kremastinos D.T., Bofilis E., Karavolias G.K., et al. Preconditioning limits myocardial infarct size in hypercholesterolemic rabbits. Atherosclerosis 150 (2000) 81-89
12. Jung O., Jung W., Malinski G., et al. Ischemic preconditioning and infarct mass: the effect of hypercholesterolemia and endothelial dysfunction. Clin Exp Hypertens 22 (2000) 165-179
13. Ueda Y., Kitakaze M., Komamura K., et al. Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction. J Am Coll Cardiol 34 (1999) 2120-2125
14. Lee T.M., Su S.F., Chou T.F., Lee Y.T., and Tsai C.H. Loss of preconditioning by attenuated activation of myocardial ATP-sensitive potassium channels in elderly patients undergoing coronary angioplasty. Circulation 105 (2002) 334-340
15. Ishihara M., Inoue I., Kawagoe T., et al. Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction. J Am Coll Cardiol 38 (2001) 1007-1111
16. 1 adenosine receptors in rabbit heart. Circulation 84 (1991) 350-356
17. Leesar M.A., Stoddard M., Ahmed M., Broadbent J., and Bolli R. Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation 95 (1997) 2500-2507
18. Iliodromitis E.K., Miki T., Liu G.S., et al. The PKC activator PMA preconditions rabbit heart in the presence of adenosine receptor blockade: is 5′-nucleotidase important?. J Mol Cell Cardiol 30 (1998) 2201-2211
19. Ross R. The pathogenesis of atherosclerosis; a perspective for the 1990s. Nature 362 (1993) 801-809
20. Iliodromitis E.K., Papadopoulos C.C., Markianos M., et al. Alterations in circulating cyclic guanosine monophosphate (c-GMP) during short and long ischemia in preconditioning. Basic Res Cardiol 91 (1996) 234-239
21. Oldenburg O., Quin Q., Sharma A.R., et al. Acetylcholine leads to free radical production dependent on KATP channels, Gi proteins, phosphatidylinositol 3-kinase and tyrosine kinase. Cardiovasc Res 55 (2002) 544-552
22. ATP channel opening and leads to cardioprotection. Am J Physiol 286 (2003) H468-H476
23. Cohen M.V., Yang X.M., Liu G.S., Heush G., and Downey J.M. Acetylcholine, bradykinin, opioids and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K ATP channels. Circ Res 89 (2001) 273-278
24. Andreadou I., Iliodromitis E.K., Mikros E., et al. Melatonin does not prevent the protection of ischemic preconditioning in vivo despite its antioxidant effect against oxidative stress. Free Radic Biol Med 37 (2004) 500-510
25. Yang X.M., Proctor J.B., Cui L., et al. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signalling pathways. J Am Coll Cardiol 44 (2004) 1103-1110
26. Kin H., Zhao Z.Q., Sun H.Y., et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 62 (2004) 74-85